![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Vamsi labs Salmeterol Xinafoate](https://www.pharmacompass.com/image/flap/vamsi-labs-salmeterol-xinafoate-desktop-headergif-90583.gif)
![Vamsi labs Salmeterol Xinafoate](https://www.pharmacompass.com/image/flap/vamsi-labs-salmeterol-xinafoate-mobgif-5116.gif)
01 1609589 (1)
02 1609590 (1)
03 1609603 (1)
04 1609614 (1)
05 1609625 (1)
06 1609680 (1)
01 Salmeterol Related Compound A (20 mg) (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol) (1)
02 Salmeterol Related Compound B (3 x 1.3 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2- (1)
03 Salmeterol Related Compound H (30 mg) (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate) (1)
04 Salmeterol Resolution Check (15 mg) (1)
05 Salmeterol System Suitability (15 mg) (1)
06 Salmeterol Xinafoate (150 mg) (1)
01 108928-81-0 (1)
02 1330076-52-2 (1)
03 1798014-51-3 (1)
04 94749-08-3 (1)
05 N/A (2)